The global arthroscopy market is expected to grow at a CAGR of around 7.3% from 2020 to 2027 and projected to reach the market value of around US$ 16.3 Bn by 2027.
Arthroscopy is a surgical procedure where orthopedic surgeons visualize, diagnose, and treat problems inside a joint. By attaching the arthroscope to a miniature television camera, the surgeon is able to view the interior of the joint by making a very small incision rather than a large incision required for surgery.
Market Drivers
Rising prevalence of musculoskeletal disorders is fuelling the demand for the arthroscopy market
According to the World Health Organization (WHO), approximate 1.71 billion people suffer from musculoskeletal conditions globally. High income countries are the most affected in terms of number of people 441 million, followed by countries in the WHO Western Pacific Region with 427 million and South-East Asia Region with 369 million. Additionally, growing demand for minimal invasive surgery is gaining high prominence for the arthroscopy market globally. In March 2013, SYMMETRY SURGICAL INC. announced new product launch namely, FlashPak® Evolution valve. Distributed by the company, the new valve's patent pending stainless steel construction is designed for ease of use and simplicity of care.
Rising prevalence of osteoarthritis and rheumatoid arthritis fuels the demand for the arthroscopy market
As per the estimates released by the Center for Disease Control and Prevention (CDC), from 2013-2015, an estimated 54.4 million US adults (22.7%) annually suffer from arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia. It is projected that by 2040, an estimated 78 million (26%) US adults aged 18 years or older will suffer from arthritis. Further, joint associated disorders are accounted 50% of chronic diseases that is prevalent in geriatric population. With the ever growing aging population, there is a growing demand for arthroscopy surgery techniques to facilitate the overall growth of the market.
New advancements in arthroscopic procedures
Stem cell research in arthroscopic surgery has gained wide prominence for conducting wide research for the growth of the arthroscopy market. Researchers from CARING MEDICAL found that the intra-auricular injection of infrapatellar fat pad derived mesenchymal stem cells (MSC) play a vital role in reducing pain and improvement in knee function in patients being treated for knee osteoarthritis. Adult MSCs can be harvested from a series of mesenchymal tissues. Originally, MSCs were isolated from bone marrow aspirate of the iliac crest. This used to be a primary source of MSCs for orthopedic knee and shoulder surgeries. For arthroscopic surgeries, a local generation of MSCs can be incorporated during daily routine without the need of an additional extraction site is favorable. Currently, only a few clinical studies with a follow-up time frame have been published concerning the application of MSCS in arthroscopic surgery in humans.
Segmental Outlook
Arthroscopy market is segmented into product and application. By product, the market is segmented as powered shaver systems, visualization systems, fluid management systems, ablation systems, arthroscopies, arthroscopy implant, and accessories and disposables. By application, the market of arthroscopy is segmented into hip arthroscopy, knee arthroscopy, shoulder arthroscopy, foot and ankle arthroscopy, hand and wrists arthroscopy, elbow arthroscopy, and sports medicines.
Arthroscopy implants will record significant market share
Based on products, arthroscopy implants have will gain substantial market share in the forecast period. This is attributed to high demand for knee arthroscopic surgery resulting in integrating demand for biodegradable implants by reducing the risk of infection and its ability to improve magnetic resonance imaging by diminishing interference. Additionally, these implants fit well and require less or no additional bending and are well-suited for diaphyseal/metaphyseal reduction. It helps in internal tissue repair, bone grafting, fixation of joints, and glenoid reconstruction fuelling the market growth of arthroscopy market globally.
By application, hip arthroscopy surgeries will dominate the arthroscopy market globally.
The advances in hip arthroscopy are rapid and recent advances in 3D imaging, instrumentation, and surgical techniques are making it possible for surgeons to perform open techniques through arthroscopy. The arthroscopy implants are inserted into the hip joint to treat labral tear. However, such challenges associated with the use of arthroscopy implants such as implant loosening, synovitis, and articular cartilage damage. These factors contribute to the fullest for overcoming and raising the adoption of arthroscope implants for hip arthroscopy.
North America is the largest arthroscopy market
North America is dominating the global arthroscopy market since the past and will continue the same trend in the forecast period. Rising prevalence of joint related disorders that highly involve arthritis, osteoarthritis, and sports related injuries are the factors that contribute to the fullest for the growth of regional market. According to the Arthritis Foundation, arthritis is the leading cause of disability among adults in the US. The prevalence of severe joint pain among adults with arthritis was stable from 2002 to 2014, but the absolute number of adults with severe joint pain was witnessed significantly higher in 2014 (14.6 million) than in 2002 (10.5 million), due to spur in the population growth. Apart from that, among the elderly population, the prevalence of degenerative knee diseases is increasing in this region coupled with rising demand for knee arthroscopy owing to prevalence of sports related injuries. Arthroscopy knee surgery for degenerative knee disease is the most common orthopedic procedure in the US. On the other hand, Asia Pacific is projected to witness significant growth in the forecast period by recording remarkable CAGR for arthroscopy market globally. In Asia Pacific, China is one of the biggest contributors for arthroscopy regional market. This is due to high incidences of musculoskeletal disorders witnessed in this region coupled with the aging population and hub of strong medical device manufacturing sector. China is also an evolving country for key companies owing to the presence of target population and high unmet medical clinical needs. The global share of China is estimated to be over 29.8% by 2024. New technological advancements in China have gained huge prominence for up surging the APAC regional growth for arthroscopic market. New visualization systems developed by the manufacturers are specialized for conducting early diagnosis and intervention of joint related disorders as they offered a clear view on the joint. Smith & Nephew, Inc. announced introduction of the hip arthroscopy system, a hip-specific set of cannula, obturators and handheld instruments designed to provide surgeons with optimal access to the hip joint.
Competitive Landscape
Key companies profiled in this report involve Arthrex GmbH, CONMED Corporation, DePuy Synthes (Johnson & Johnson Family), Smith & Nephew plc, Stryker Corporation, Zimmer Biomet, and BioTek Instruments, Inc., and among others.
Market Segmentation
Market By Product
Powered Shaver Systems
Visualization Systems
Fluid Management Systems
Ablation Systems
Arthroscopes
Arthroscope Implants
Accessories and Disposables
Market By Application
Hip Arthroscopy
Knee Arthroscopy
Shoulder Arthroscopy
Foot and Ankle Arthroscopy
Hand and Wrist Arthroscopy
Elbow Arthroscopy
Sports Medicines
Market By Geography
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Arthroscopy is expected to reach a market value of around US$ 16.3 Bn by 2027.
The arthroscopy market is expected to grow at a CAGR of around 7.3% from 2020 to 2027.
By product, arthroscopy implants is the leading segment in the overall market.
Rising prevalence of osteoarthritis and rheumatoid arthritis is one of the prominent factors that drive the demand for arthroscopy market.
Arthrex GmbH, CONMED Corporation, DePuy Synthes (Johnson & Johnson Family), Smith & Nephew plc, Stryker Corporation, Zimmer Biomet, and BioTek Instruments, Inc., and among others.
North America is anticipated to grab the highest market share in the regional market
Asia Pacific is expected to be the fastest growing market in the forthcoming years